Business Segment Information Level 3 (Tables)

9 Months Ended

Dec. 31, 2013

Notes To Financial Statements [Abstract]

Schedule of Segment Reporting Information, by Segment [Table Text Block]

Financial information for each of our segments is presented in the following tables:

	Three Months Ended December 31,						Nine Months Ended December 31,
	2013			2012			2013			2012
Revenues:
Healthcare (1)	$	291,831		$	271,096		$	828,051		$	757,430
Life Sciences	64,128			65,043			182,425			180,116
Isomedix	49,157			43,392			144,792			133,732
Total reportable segments	405,116			379,531			1,155,268			1,071,278
Corporate and other	435			874			1,697			2,408
Total revenues	$	405,551		$	380,405		$	1,156,965		$	1,073,686
Operating income:
Healthcare (2)	$	31,238		$	45,478		$	72,111		$	110,355
Life Sciences	12,092			12,798			38,672			35,201
Isomedix	14,054			11,103			42,484			39,348
Total reportable segments	57,384			69,379			153,267			184,904
Corporate and other	(1,494		)	(2,239		)	(6,065		)	(7,185		)
Total operating income	$	55,890		$	67,140		$	147,202		$	177,719

(1) Includes an increase of $20,400 in the fiscal 2013 nine months ended December 31, 2012 period, resulting from adjustments related to the SYSTEM 1 Rebate Program.

(2) Includes an increase of $15,800 in the fiscal 2013 three months ended December 31, 2012 period and $37,300 in the fiscal 2013 nine months ended December 31, 2012 period, resulting from adjustments related to the SYSTEM 1 Rebate Program and class action settlement.